MedPath

A study on the characteristics of a subtype of Breast cancer in a tertiary care hospital.

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2023/01/048834
Lead Sponsor
Kasturba Medical College, Manipal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All triple negative breast cancer patients above the age of 18

Exclusion Criteria

Patients with incomplete information regarding ER, PR, HER2/neu status.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of Triple negative breast cancer at our hospital. <br/ ><br>Pathological complete response in patients of Triple negative breast cancer. <br/ ><br>Surgical outcome in Triple negative breast cancer patients who underwent Neoadjuvant chemotherapy/radiation.Timepoint: 7 days post surgery
Secondary Outcome Measures
NameTimeMethod
Role of Neutrophil:Lymphocyte ratio in predicting Pathological complete response in Triple negative breast cancer.Timepoint: At admission and 7 days post surgery
© Copyright 2025. All Rights Reserved by MedPath